Aminoglycoside-induced hearing deficits – a review of cochlear ototoxicity

References

• Cannizzaro E, Cannizzaro C, Plescia F, et al. Exposure to ototoxic agents and hearing loss: a review of current knowledge. Hear Balan Commun. 2014;12(4):166–75.10.3109/21695717.2014.964939
   Google Scholar
• World Health Organization. Global Tuberculosis Report. Geneva: World Health Organization; 2012.
   Google Scholar
• Barclay M, Begg E. Aminoglycoside toxicity and relation to drug regimen. Adverse Drug React Toxicol Rev. 1994;13(4):207–34.
   PubMedGoogle Scholar
• Bennett C. The aminoglycosides. Prim Care Update Ob Gyns. 1996;3:186–91.10.1016/S1068-607X(96)00025-X
   Google Scholar
• Guthrie OW. Aminoglycoside induced ototoxicity. Toxicology. 2008;249(2-3):91–6.10.1016/j.tox.2008.04.015
   PubMed Web of Science ®Google Scholar
• Hashino E, TinHan E, Salvi R. Base-to-apex gradient of cell proliferation in the chick cochlea following kanamycin-induced hair cell loss. Hear Res. 1995;88:156–68.10.1016/0378-5955(95)00109-H
   PubMed Web of Science ®Google Scholar
• Henley CM, Weatherly RA, Martin GK, et al. Sensitive developmental periods for kanamycin ototoxic effects on distortion-product otoacoustic emissions. Hear Res. 1996;98:93–103.10.1016/0378-5955(96)00077-9
   PubMed Web of Science ®Google Scholar
• Hall JW. Otoacoustic emissions. San Diego, CA: Singular; 2000.
   Google Scholar
• Konrad-Martin D, Wilmington DJ, Gordon JS, et al. Audiological management of patients receiving aminoglycoside antibiotics. Volta Rev. 2005;105(3):229–50.
   Web of Science ®Google Scholar
• American Speech-Language-Hearing Association. Audiologic management of Individuals Receiving Cochleotoxic Drug Therapy [ Guidelines]. 1994. Available from: www.asha.org/policy
   Google Scholar
• Edson RS, Terrell CL. The Aminoglycosides. Mayo Clin Proc. 1999;74:519–28.10.1016/S0025-6196(11)65134-3
   PubMed Web of Science ®Google Scholar
• Arslan E, Orzan E, Santarelli R. Global problem of drug-induced hearing loss. Ann N Y Acad Sci. 1999;884:1–14.
   PubMed Web of Science ®Google Scholar
• Mulrow CD, Aguilar C, Endicott JE, et al. Association between hearing impairment and the quality of life of elderly individuals. J Am Geriatr Soc. 1990;38:45–50.
   PubMed Web of Science ®Google Scholar
• Ruben RJ. Redefining the survival of the fittest: communication disorders in the 21st century. Laryngoscope. 2000;110:241–5.10.1097/00005537-200002010-00010
   PubMed Web of Science ®Google Scholar
• Miyakita T, Ueda A, Zusho H, et al. Self-evaluation scores of hearing difficulties and quality of life components among retired workers with noise-related hearing loss. J Sound Vibration. 2002;250:119–28.10.1006/jsvi.2001.3898
   Web of Science ®Google Scholar
• Cohen SM, Labadie RF, Dietrich MS, Haynes DS. Quality of life in hearing-impaired adults: the role of cochlear implants and hearing aids. Otolaryngol Head Neck Surg. 2004;131(4):413–22.10.1016/j.otohns.2004.03.026
   PubMed Web of Science ®Google Scholar
• Department of Health. Management of drug-resistant tuberculosis: policy guidelines. Pretoria: Department of Health; 2011.
   Google Scholar
• Ramma L, Ibekwe TS. Cochleo-vestibular clinical findings among drug resistant tuberculosis patients on therapy-a pilot study. Int Arch Med. 2012;5(1):1–5.
   PubMedGoogle Scholar
• Harris T, Bardien S, Schaaf HS, et al. Aminoglycoside-induced hearing loss in HIV-positive and HIV-negative multidrug-resistant tuberculosis patients. S Afr Med J. 2012;102(6):363–6.
   PubMed Web of Science ®Google Scholar
• Seddon JA, Thee S, Jacobs K, et al. Hearing loss in children treated for multidrug-resistant tuberculosis. J Infect. 2013;6:320–9.
   Web of Science ®Google Scholar
• Lerner SA, Matz GJ. Suggestions for monitoring patients during treatment with aminoglycoside antibiotics. Otolaryngol Head Neck Surg. 1979;87:222–8.
   PubMed Web of Science ®Google Scholar
• Kucers A, Bennett N. The use of antibiotics: a comprehensive review with clinical emphasis. London: William Heinemann Medical Books; 1987.
   Google Scholar
• Voogt G, Schoeman H. Ototoxicity of aminoglycoside drugs in tuberculosis treatment. S Afr J Commun Disord. 1996;43:3–6.
   PubMedGoogle Scholar
• Al-Malky G, Suri R, Dawson SJ, et al. Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: a study using extended high-frequency audiometry and distortion product otoacoustic emissions. Int J Audiol 2011;50(2):112–22.10.3109/14992027.2010.524253
   PubMed Web of Science ®Google Scholar
• Monsell EM, Teixido MT, Wilson MD, et al. Nonhereditary hearing loss: ototoxicity. In: Hughes GB, Pensak ML, editors. Clinical otology. 2nd ed. New York, NY: Thieme Medical Publishers, Inc.; 1997. p. 289–305.
   Google Scholar
• De Jager P, van Altena R. Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis. Int J Tuberc Lung Dis. 2002;6(7):622–7.
   PubMed Web of Science ®Google Scholar
• Duggal P, Sarkar M. Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up. Biomed Central Ear Nose Throat Disorders. 2007;7(5):1–7.
   PubMedGoogle Scholar
• Fausti SA, Frey RH, Henry JA, et al. High frequency testing techniques and instrumentation for early detection of ototoxicity. J Rehabil Res Dev. 1993;30(3):333–41.
   PubMed Web of Science ®Google Scholar
• Fee WE. Aminoglycoside ototoxicity in the human. Laryngoscope. 1980;90(S24):1–19.10.1288/00005537-198010001-00001
   PubMed Web of Science ®Google Scholar
• Hotz M, Harris F, Probst R. Otoacoustic emissions: an approach for monitoring aminoglycoside-induced ototoxicity. Laryngoscope. 1994;104:1130–4.
   PubMed Web of Science ®Google Scholar
• Moore RD, Smith CR, Lietman PS. Risk factors for the development of auditory toxicity in patients receiving aminoglycosides. J Infect Dis. 1984;149:22–30.
   Google Scholar
• Sturdy A, Goodman A, Jose RJ, et al. Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice. J Antimicrob Chemother. 2011;66(8):1815–20.10.1093/jac/dkr221
   PubMed Web of Science ®Google Scholar
• Schacht J. Aminoglycoside antibiotics. In: Campbell KCM, editor. Pharmacology and ototoxicity for audiologists. New York, NY: Thomson Delmar Learning; 2007. p. 163–76.
   Google Scholar
• Troost BT, Waller MA. Drug induced vestibulocochlear toxicity. In: Biller J, editor. Iatrogenic neurology. Boston, MA: Butterworth-Heinemann; 1998. p. 253–67.
   Google Scholar
• Kumana CR, Yuen KY. Parenteral aminoglycoside therapy. Drugs. 1994;47(6):902–13.10.2165/00003495-199447060-00004
   PubMed Web of Science ®Google Scholar
• Bastian I, Colebunders R. Treatment and prevention of multidrug-resistant tuberculosis. Drugs. 1999;58:633–61.10.2165/00003495-199958040-00005
   PubMed Web of Science ®Google Scholar
• Fausti SA, Henry JA, Schaffer HI, et al. High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity. J Infect Dis. 1992;165(6):1026–32.10.1093/infdis/165.6.1026
   PubMed Web of Science ®Google Scholar
• Mavros MN, Polyzos KA, Rafailidis PI, et al. Once versus multiple daily dosing of aminoglycosides for patients with febrile neutropenia: a systematic review and meta-analysis. J Antimicrob Chemother. 2011 Feb;66(2):251–9.10.1093/jac/dkq451
   PubMed Web of Science ®Google Scholar
• Smyth AR, Bhatt J. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis. Cochrane Database of Syst Rev. 2010;(1) Art. No.: CD002009. doi: 10.1002/14651858.CD002009.pub3
   Web of Science ®Google Scholar
• Cianfrone G, Pentangelo D, Cianfrone F, et al. Pharmacological drugs inducing ototoxicity, vestibular symptoms and tinnitus: a reasoned and updated guide. Eur Rev Med Pharmacol Sci. 2011;15(6):601–36.
   PubMed Web of Science ®Google Scholar
• Avent ML, Rogers BA, Cheng AC, et al. Current use of aminoglycosides, indications, pharmacokinetics and monitoring for toxicity. Intern Med J. 2011;41(6):441–9.10.1111/imj.2011.41.issue-6
   PubMed Web of Science ®Google Scholar
• Kastner M, Estey E, Perrier L, et al. Understanding the relationship between the perceived characteristics of clinical practice guidelines and their uptake: protocol for a realist review. Implement Sci. 2011;6(69):1–9.
   PubMed Web of Science ®Google Scholar
• Neuwelt EA, Brock P. Critical need for international consensus on ototoxicity assessment criteria. J Clin Oncol. 2010;28(10):1630–2.10.1200/JCO.2009.26.7872
   PubMed Web of Science ®Google Scholar
• Pereira de Faria L, De Bortoli Cassiani S. Interação medicamentosa: conhecimento de enfermeiros das unidades de terapia intensiva. Acta Paulista de Enfermagem. 2011;24(2):264–70.10.1590/S0103-21002011000200017
   Google Scholar
• Van der Walt H. Too close for comfort: emotional ties between nurse and patients. In: Swartz L, Gibson K, Gelman T, editors. Reflective practice: psychodynamic ideas in the community. Cape Town: Human Sciences Research Council; 2002.
   Google Scholar
• Black FO, Pesznecker SC. Vestibular ototoxicity. Otolaryngol Clin North Am. 1993;20:713–36.
   Google Scholar
• Lustig LR, Niparko JK. Sensori-neural hearing loss. In: Lustig LR, Niparko JK, editors. Clinical neurotology London: Martin Dunitz Ltd; 2003. p. 161–74.
   Google Scholar
• Matz GJ. Aminoglycoside ototoxicity. Otolaryngol Clin North Am. 1993;26(5):705–12.
   PubMed Web of Science ®Google Scholar
• Vasquez R, Mattucci KF. A proposed protocol for monitoring ototoxicity in patients who take cochleo- or vestibulotoxic drugs. Ear Nose Throat J. 2003;82(3):181–4.
   PubMedGoogle Scholar
• Dhanireddy S, Liles WC, Gates GA. Vestibular toxic effects induced by once-daily aminoglycoside therapy. Arch Otolaryngol Head Neck Surg. 2005;131:46–8.
   PubMed Web of Science ®Google Scholar
• American Academy of Audiology. Position statement and clinical practice guidelines: Ototoxicity monitoring. American Academy of Audiology; 2009.
   Google Scholar
• Reavis KM, McMillan G, Austin D, et al. Distortion-product otoacoustic emission test performance for ototoxicity monitoring. Ear Hear. 2011;32:61–74.
   PubMed Web of Science ®Google Scholar
• Probst R, Harris FP, Hauser R. Clinical monitoring using otoacoustic emissions. Br J Audiol. 1993;27(2):85–90.10.3109/03005369309077896
   PubMed Web of Science ®Google Scholar
• Dreschler WA, v.d. Hulst RJ, Tange RA, et al. The role of high-frequency audiometry in early detection of ototoxicity. Audiology. 1985;24:387–95.10.3109/00206098509078358
   PubMed Web of Science ®Google Scholar
• Stavroulaki P, Apostolopoulos N, Dinopoulou D, et al. Otoacoustic emissions — an approach for monitoring aminoglycoside induced ototoxicity in children. Int J Pediatr Otorhinolaryngol. 1999 11/5;50(3):177–84.10.1016/S0165-5876(99)00247-5
   PubMed Web of Science ®Google Scholar
• Dhar S, Hall JW. Otoacoustic emissions: principles, procedures and protocols. San Diego, CA: Plural Publishing; 2012.
   Google Scholar
• Harris F, Probst R. Otoacoustic emissions and audiometric outcomes. In: Robinette MS, Glattke TJ, editors. Otoacoustic emissions: clinical applications. 2nd ed. New York, NY: Thieme; 2002. p. 213–42.
   Google Scholar
• Kemp DT. Stimulated acoustic emissions from within the human auditory system. J Acoust Soc Am. 1978;64(5):1386–91.10.1121/1.382104
   PubMed Web of Science ®Google Scholar
• Roland PS. New developments in our understanding of ototoxicity. Ear Nose Throat J. 2004;83(9, Suppl 4):15–7.
   PubMedGoogle Scholar
• Aksoy F, Dogan R, Ozturan O, et al. Protective effect of trimetazidine on amikacin-induced ototoxicity in rats. Int J Pediatr Otorhinolaryngol. 2014;78(4):663–9.10.1016/j.ijporl.2014.01.031
   PubMed Web of Science ®Google Scholar
• Sha S, Taylor R, Forge A, et al. Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals. Hear Res. 2001;155:1–8.10.1016/S0378-5955(01)00224-6
   PubMed Web of Science ®Google Scholar
• Yang TH, Young YH, Liu SH. EGb 761 (Ginkgo biloba) protects cochlear hair cells against ototoxicity induced by gentamicin via reducing reactive oxygen species and nitric oxide-related apoptosis. J Nutr Biochem. 2011;22(9):886–94.10.1016/j.jnutbio.2010.08.009
   PubMed Web of Science ®Google Scholar
• Cotanche DA, Kaiser CL. Hair cell fate decisions in cochlear development and regeneration. Hear Res. 2010;266:18–25.10.1016/j.heares.2010.04.012
   PubMed Web of Science ®Google Scholar
• Matsui JI, Parker MA, Ryals BM, et al. Regeneration and replacement in the vertebrate inner ear. Drug Discov Today. 2005;10(19):1307–12.10.1016/S1359-6446(05)03577-4
   PubMed Web of Science ®Google Scholar
• English WP, Williams MD. Should aminoglycoside antibiotics be abandoned? Am J Surg. 2000 12;180(6):512–6.10.1016/S0002-9610(00)00539-0
   PubMed Web of Science ®Google Scholar